AstraZeneca's silence on CEO wipes out £billions

ReutersNewsPublished: July 14, 20171 views
Published: July 14, 2017

Uncertainty over the future of AstraZeneca Chief Executive Pascal Soriot drove the Anglo-Swedish drugmaker's shares lower again on Friday, taking the cost of two days of silence to more than 3 billion pounds ($3.9 billion). Ciara Lee reports.

Be the first to suggest a tag